Search research articles
Contact Us
Filters
Showing results (1-10 of 68) with videos related to
Page
of 7
Sort By:
The Lancet. Global Health
|
February 16, 2024
Seasonal malaria chemoprevention: drug design and selection
Issaka Zongo, Yves Daniel Compaoré
Tropical Medicine and Infectious Disease
|
January 24, 2025
Assessing the Acceptability and Feasibility of Five Cycles of Seasonal Malaria Chemoprevention in Côte d'Ivoire
Orphée Kangah, Issaka Zongo, Alassane Haro, et al.
Malaria Journal
|
March 10, 2022
Resurgent and delayed malaria
Brian Greenwood, Issaka Zongo, Alassane Dicko, et al.
Tropical Medicine & International Health : TM & IH
|
February 29, 2008
Chloroquine-resistance molecular markers (Pfcrt T76 and Pfmdr-1 Y86) and amodiaquine resistance in Burkina Faso
Halidou Tinto, Lougué Guekoun, Issaka Zongo, et al.
The American Journal of Tropical Medicine and Hygiene
|
July 14, 2006
Roles of specific Plasmodium falciparum mutations in resistance to amodiaquine and sulfadoxine-pyrimethamine in Burkina Faso
Christian Dokomajilar, Zambende Moise Lankoande, Grant Dorsey, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 12, 2005
Amodiaquine, sulfadoxine-pyrimethamine, and combination therapy for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso
Issaka Zongo, Grant Dorsey, Noel Rouamba, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 9, 2007
Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso
Issaka Zongo, Grant Dorsey, Noel Rouamba, et al.
The American Journal of Tropical Medicine and Hygiene
|
April 12, 2007
Sulfadoxine-pyrimethamine efficacy and selection of Plasmodium falciparum DHFR mutations in Burkina Faso before its introduction as intermittent preventive treatment for pregnant women
Halidou Tinto, Jean Bosco Ouédraogo, Issaka Zongo, et al.
Parasite Epidemiology and Control
|
January 5, 2026
Epidemiology of <i>Schistosoma haematobium</i> infection and microhaematuria among schoolchildren in a setting of sustained mass drug administration in Banfora, Burkina Faso
Mamoudou Cissé, Alamissa Soulama, Constant Sirima, et al.
Antimicrobial Agents and Chemotherapy
|
April 16, 2014
Selection of drug resistance-mediating Plasmodium falciparum genetic polymorphisms by seasonal malaria chemoprevention in Burkina Faso
Anyirékun Fabrice Somé, Issaka Zongo, Yves-Daniel Compaoré, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 68) with videos related to
Sort By:
Page
of 7
The Lancet. Global Health
|
February 16, 2024
Seasonal malaria chemoprevention: drug design and selection
Issaka Zongo, Yves Daniel Compaoré
Tropical Medicine and Infectious Disease
|
January 24, 2025
Assessing the Acceptability and Feasibility of Five Cycles of Seasonal Malaria Chemoprevention in Côte d'Ivoire
Orphée Kangah, Issaka Zongo, Alassane Haro, et al.
Malaria Journal
|
March 10, 2022
Resurgent and delayed malaria
Brian Greenwood, Issaka Zongo, Alassane Dicko, et al.
Tropical Medicine & International Health : TM & IH
|
February 29, 2008
Chloroquine-resistance molecular markers (Pfcrt T76 and Pfmdr-1 Y86) and amodiaquine resistance in Burkina Faso
Halidou Tinto, Lougué Guekoun, Issaka Zongo, et al.
The American Journal of Tropical Medicine and Hygiene
|
July 14, 2006
Roles of specific Plasmodium falciparum mutations in resistance to amodiaquine and sulfadoxine-pyrimethamine in Burkina Faso
Christian Dokomajilar, Zambende Moise Lankoande, Grant Dorsey, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 12, 2005
Amodiaquine, sulfadoxine-pyrimethamine, and combination therapy for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso
Issaka Zongo, Grant Dorsey, Noel Rouamba, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 9, 2007
Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso
Issaka Zongo, Grant Dorsey, Noel Rouamba, et al.
The American Journal of Tropical Medicine and Hygiene
|
April 12, 2007
Sulfadoxine-pyrimethamine efficacy and selection of Plasmodium falciparum DHFR mutations in Burkina Faso before its introduction as intermittent preventive treatment for pregnant women
Halidou Tinto, Jean Bosco Ouédraogo, Issaka Zongo, et al.
Parasite Epidemiology and Control
|
January 5, 2026
Epidemiology of <i>Schistosoma haematobium</i> infection and microhaematuria among schoolchildren in a setting of sustained mass drug administration in Banfora, Burkina Faso
Mamoudou Cissé, Alamissa Soulama, Constant Sirima, et al.
Antimicrobial Agents and Chemotherapy
|
April 16, 2014
Selection of drug resistance-mediating Plasmodium falciparum genetic polymorphisms by seasonal malaria chemoprevention in Burkina Faso
Anyirékun Fabrice Somé, Issaka Zongo, Yves-Daniel Compaoré, et al.
Page
of 7